EARS Description — Altamira Therapeutics Ltd
Auris Medical Holding is a holding company. Through its subsidiaries, Co. is a clinical-stage biopharmaceutical company focused on the development of products that address medical needs in neurotology and mental health supportive care. Co. is focusing on the development of intranasal betahistine for the treatment of vertigo and for the prevention of antipsychotic-induced weight gain and somnolence. In addition, Co. has two programs under development: Keyzilen®, which is being developed for the treatment of acute inner ear tinnitus; and Sonsuvi®, which is being developed for the treatment of acute inner ear hearing loss.